Mark Versavel
Overview
Mark Versavel received $357K in total compensation at NeuroBo Pharmaceuticals in 2020.
Source: SEC filing on June 15, 2021.
Related executives
We found 13 more executives who work or worked at NeuroBo Pharmaceuticals.
Hyung Kim
NeuroBo Pharmaceuticals
Chief Executive Officer
Joseph Hooker
NeuroBo Pharmaceuticals
Chief Executive Officer
Marshall Woodworth
NeuroBo Pharmaceuticals
Chief Financial Officer
Gil Price
NeuroBo Pharmaceuticals
Chief Executive Officer
Ben Price
NeuroBo Pharmaceuticals
Chief Executive Officer
Richard Kang
NeuroBo Pharmaceuticals
Chief Executive Officer
Akash Bakshi
NeuroBo Pharmaceuticals
Chief Operating Officer
Nicola Shannon
NeuroBo Pharmaceuticals